| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Revenue | ₹163.11 | ₹153.76 | ₹96.80 |
| Other Income | ₹0.64 | ₹1.42 | ₹0.23 |
| Total Revenue | ₹163.74 | ₹155.18 | ₹97.03 |
| Total Expenses | ₹143.84 | ₹142.63 | ₹89.78 |
| Profit Before Tax | ₹19.91 | ₹12.56 | ₹7.25 |
| Tax | ₹5.48 | ₹4.14 | ₹2.87 |
| Profit After Tax | ₹14.43 | ₹8.42 | ₹4.38 |
| EPS - Basic | ₹5.43 | ₹10.54 | ₹6.16 |
| EPS - Diluted | ₹5.43 | ₹10.54 | ₹6.16 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Profit before tax | ₹19.91 | ₹12.56 | ₹7.25 |
| Income before WC changes | ₹40.34 | ₹33.25 | ₹18.82 |
| Change in Assets | -₹14.87 | -₹101.20 | -₹39.64 |
| Change in Liabilities | ₹8.23 | ₹38.12 | ₹10.71 |
| Change in WC | -₹6.64 | -₹63.08 | -₹28.92 |
| Cash flow from Operations | ₹33.15 | -₹29.76 | -₹12.80 |
| Cash flow from Investing | ₹0.44 | -₹46.32 | -₹19.03 |
| Cash flow from Financing | -₹35.88 | ₹78.57 | ₹23.98 |
| Total Cash Flow | -₹2.30 | ₹2.48 | -₹7.85 |
| Cash (Start of the year) | ₹4.38 | ₹1.90 | ₹9.75 |
| Cash (End of the year) | ₹2.09 | ₹4.38 | ₹1.91 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Non-Current Assets | ₹72.47 | ₹80.75 | ₹52.02 |
| Current Assets | ₹199.92 | ₹187.35 | ₹81.94 |
| Total Assets | ₹272.39 | ₹268.10 | ₹133.96 |
| Current Liabilities | ₹162.35 | ₹152.79 | ₹76.63 |
| Net Current Asset | ₹37.57 | ₹34.56 | ₹5.31 |
| Non-Current Liabilities | ₹14.25 | ₹38.91 | ₹25.84 |
| Equity Capital | ₹95.78 | ₹76.40 | ₹31.49 |
| Total Equity & Liabilities | ₹272.39 | ₹268.10 | ₹133.96 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Revenue | ₹124.27 | ₹113.89 | ₹96.80 |
| Other Income | ₹0.24 | ₹1.09 | ₹0.19 |
| Total Revenue | ₹124.51 | ₹114.97 | ₹96.98 |
| Total Expenses | ₹110.10 | ₹104.74 | ₹89.75 |
| Profit Before Tax | ₹14.39 | ₹10.20 | ₹7.25 |
| Tax | ₹4.05 | ₹3.04 | ₹2.67 |
| Profit After Tax | ₹10.34 | ₹7.16 | ₹4.58 |
| EPS - Basic | ₹3.89 | ₹8.95 | ₹6.46 |
| EPS - Diluted | ₹3.89 | ₹8.95 | ₹6.46 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Profit before tax | ₹14.39 | ₹10.20 | ₹7.25 |
| Income before WC changes | ₹27.06 | ₹22.49 | ₹18.70 |
| Change in Assets | -₹22.38 | -₹34.71 | -₹40.42 |
| Change in Liabilities | ₹9.17 | ₹11.01 | ₹3.59 |
| Change in WC | -₹13.21 | -₹23.71 | -₹36.83 |
| Cash flow from Operations | ₹9.80 | -₹4.43 | -₹20.83 |
| Cash flow from Investing | -₹4.27 | -₹31.97 | -₹17.26 |
| Cash flow from Financing | -₹5.81 | ₹35.88 | ₹30.23 |
| Total Cash Flow | -₹0.29 | -₹0.52 | -₹7.85 |
| Cash (Start of the year) | ₹1.38 | ₹1.91 | ₹9.76 |
| Cash (End of the year) | ₹1.10 | ₹1.38 | ₹1.91 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Non-Current Assets | ₹82.74 | ₹73.56 | ₹48.25 |
| Current Assets | ₹132.41 | ₹120.48 | ₹85.72 |
| Total Assets | ₹215.15 | ₹194.04 | ₹133.97 |
| Current Liabilities | ₹111.32 | ₹97.27 | ₹76.63 |
| Net Current Asset | ₹21.09 | ₹23.21 | ₹9.09 |
| Non-Current Liabilities | ₹12.49 | ₹18.69 | ₹25.86 |
| Equity Capital | ₹91.34 | ₹78.08 | ₹31.48 |
| Total Equity & Liabilities | ₹215.15 | ₹194.04 | ₹133.97 |
SAI PARENTERALS LIMITED share price is ₹618.60 as on 03 Jul, 2026, 15:56 IST.
In the last 1 year, SAI PARENTERALS LIMITED delivered a return of 52.48%. The SAI PARENTERALS LIMITED share price hit a high of ₹706.00 and low of ₹400.00.
The Mutual Fund Shareholding in SAI PARENTERALS LIMITED was 3.81% at the end of Apr 2026.
The 52-week high and low of SAI PARENTERALS LIMITED share is ₹706.00 and ₹400.00 as of 03 Jul, 2026.
The market capitalisation of SAI PARENTERALS LIMITED is ₹0.00 Crores as on 03 Jul, 2026.
The stock symbol of SAI PARENTERALS LIMITED is SAIPARENT on the NSE, 544742 on the BSE, and the ISIN is INE0H9F01037.
To buy SAI PARENTERALS LIMITED shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
SAI PARENTERALS LIMITED shares closed yesterday at ₹623.80 on NSE & ₹623.70 on BSE
No, shares of SAI PARENTERALS LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell SAI PARENTERALS LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.